| 4-ANI | 4-amino-1,8-naphthalimide |
| ACE2 | Angiotensin-converting enzyme 2 |
| ARDS | Acute respiratory distress syndrome |
| COVID-19 | Corona virus disease 2019 |
| CD14 | Cluster of differentiation 14 |
| Dex | Dexamethasone |
| DMEM | Dulbecco’s Modified Eagle’s Medium |
| ELISA | Enzyme-linked Immunosorbent Assay |
| EtOH | Ethanol |
| FCS | Fetal calf serum |
| IL | Interleukin |
| LPS | Lipopolysaccharide |
| MedDRA | Medical Dictionary for Regulatory Activities |
| PARP1 | Poly (ADP-ribose) polymerase 1 |
| PASI | Psoriasis Area and Severity Index |
| PBMC | Peripheral blood mononuclear cells |
| PBS | Phosphate-buffered saline |
| PM | Peritoneal macrophages |
| PMA | Phorbol 12-myristate 13-acetate |
| RFU | Relative fluorescence units |
| ROS | Reactive oxygen species |
| RPMI | Roswell Park Memorial Institute medium |
| SAE | Serious adverse event |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus type 2 |
| SDS-PAGE | Sodium dodecyl sulfate polyacrylamide gel electrophoresis |
| SEM | Standard error of the mean |
| TEAE | Treatment-emergent adverse event |
| TNFα | Tumor necrosis factor-alpha |
| UPE | Ultra-weak photon emission |
| WST-1 | Water-soluble tetrazolium salt 1 assay |